Bertrand Damour is the founder of Pheon Therapeutics. Pheon Therapeutics has raised $68M in total funding. Latest round: Series A. Based in London, UK.
Bertrand Damour is the Chief Executive Officer of Pheon Therapeutics, a company specializing in next-generation Antibody-Drug Conjugates (ADCs) for hard-to-treat cancers. Pheon Therapeutics launched with a $68 million Series A financing in March 2022. Damour has over 20 years of management experience in the biotech industry, previously serving as CEO of multiple companies including NBE Therapeutics, which was acquired by Boehringer Ingelheim.
Full founder directory · Investor directory · Company funding database · Fundraising library